Prognosis
The prognosis for patients with gastrointestinal carcinoid tumour is:
- with no metastases - median survival 5-8 years
- with metastases - median survival 38 months
Five-year survival rate of patients is approximately 75.1% in the stomach, 76.1% in the small intestine, 76.1% in the appendix, and 87.5% in the rectum (3)
Poor prognostic factors are (3):
- carcinoid heart disease and high levels of tumor markers,
- liver metastasis,
- involvement of the thymus,
- overexpression of the proliferation of Ki67,
- mutation of the p53 gene
Reference:
- Endocr Relat Cancer. 2004 Mar;11(1):1-18.
- de Herder WW and Lamberts SWJ. Best Practice & Research Clinical Endocrinology & Metabolism 2004; Volume 18(4): 477-495.
- Gade AK, Olariu E, Douthit NT. Carcinoid Syndrome: A Review. Cureus. 2020 Mar 5;12(3):e7186. doi: 10.7759/cureus.7186.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page